Treatment Options for Relapsed and Refractory Multiple Myeloma : Multiple MyelomaLONIAL, Sagar; MITSIADES, Constantine S; RICHARDSON, Paul G et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1264-1277, issn 1078-0432, 14 p.Article

From the bench to the bedside : emerging new treatments in multiple myelomaHAYDEN, Patrick J; MITSIADES, Constantine S; ANDERSON, Kenneth C et al.Targeted oncology. 2008, Vol 3, Num 1, pp 19-29, issn 1776-2596, 11 p.Article

Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapyKARAMANAKOS, Peter; MITSIADES, Constantine S; LEMBESSIS, Peter et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1077-1081, issn 0250-7005, 5 p.Article

Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. Zoledronate in patients with androgen ablation-refractory prostate cancerMITSIADES, Constantine S; BOGDANOS, John; KARAMANOLAKIS, Dimitrios et al.Anticancer research. 2006, Vol 26, Num 5B, pp 3693-3700, issn 0250-7005, 8 p.Article

Proteasome inhibition as a therapeutic strategy for hematoloqic maliqnanciesMITSIADES, Constantine S; MITSIADES, Nicholas; HIDESHIMA, Teru et al.Expert review of anticancer therapy. 2005, Vol 5, Num 3, pp 465-476, issn 1473-7140, 12 p.Article

Novel biologically based therapies for Waldenstrom's macroglobulinemiaMITSIADES, Constantine S; MITSIADES, Nicholas; RICHARDSON, Paul G et al.Seminars in oncology. 2003, Vol 30, Num 2, pp 309-312, issn 0093-7754, 4 p.Article

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cellsMITSIADES, Nicholas; MITSIADES, Constantine S; POULAKI, Vassiliki et al.Blood. 2002, Vol 99, Num 6, pp 2162-2171, issn 0006-4971Article

Management of Relapsed and Relapsed Refractory MyelomaKASTRITIS, Efstathios; MITSIADES, Constantine S; DIMOPOULOS, Meletios A et al.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, x, 1175-1215 [42 p.]Article

Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseasesMITSIADES, Nicholas; POULAKI, Vassiliki; MITSIADES, Constantine S et al.Trends in endocrinology and metabolism. 2001, Vol 12, Num 9, pp 384-390, issn 1043-2760Article

Novel therapies in myelomaHAYDEN, Patrick J; MITSIADES, Constantine S; ANDERSON, Kenneth C et al.Current opinion in hematology. 2007, Vol 14, Num 6, pp 609-615, issn 1065-6251, 7 p.Article

Constitutive nuclear factor-κB activity is crucial for human retinoblastoma cell viabilityPOULAKI, Vassiliki; MITSIADES, Constantine S; JOUSSEN, Antonia M et al.The American journal of pathology. 2002, Vol 161, Num 6, pp 2229-2240, issn 0002-9440, 12 p.Article

The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma : Interplay of growth factors, their receptors and stromal interactionsMITSIADES, Constantine S; MITSIADES, Nicholas S; MUNSHI, Nikhil C et al.European journal of cancer (1990). 2006, Vol 42, Num 11, pp 1564-1573, issn 0959-8049, 10 p.Article

Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathyPOULAKI, Vassiliki; JOUSSEN, Antonia M; MITSIADES, Nicholas et al.The American journal of pathology. 2004, Vol 165, Num 2, pp 457-469, issn 0002-9440, 13 p.Article

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applicationsMITSIADES, Constantine S; TREON, Steven P; MITSIADES, Nicholas et al.Blood. 2001, Vol 98, Num 3, pp 795-804, issn 0006-4971Article

Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancersRICHARDSON, Paul G; MITSIADES, Constantine S; LAUBACH, Jacob P et al.British journal of haematology. 2011, Vol 152, Num 4, pp 367-379, issn 0007-1048, 13 p.Article

Molecular Sequelae of Histone Deacetylase Inhibition in Human Retinoblastoma Cell Lines: Clinical ImplicationsPOULAKI, Vassiliki; MITSIADES, Constantine S; KOTOULA, Vassiliki et al.Investigative ophthalmology & visual science. 2009, Vol 50, Num 9, pp 4072-4079, issn 0146-0404, 8 p.Article

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitroPOULAKI, Vassiliki; MITSIADES, Constantine S; KOTOULA, Vassiliki et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 10, pp 4706-4719, issn 0146-0404, 14 p.Article

Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cellsPOULAKI, Vassiliki; MITSIADES, Constantine S; KOTOULA, Vassiliki et al.The American journal of pathology. 2002, Vol 161, Num 2, pp 643-654, issn 0002-9440Article

JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cellsKIZILTEPE, Tanyel; HIDESHIMA, Teru; KUTOK, Jeffery L et al.Blood. 2007, Vol 110, Num 2, pp 709-718, issn 0006-4971, 10 p.Article

The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective TherapiesMITSIADES, Constantine S; MCMILLIN, Douglas W; KLIPPEL, Steffen et al.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, vii-viii, 1007-1034 [30 p.]Article

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma : Mutational and functional analysisMITSIADES, Constantine S; KOTOULA, Vassiliki; POULAKI, Vassiliki et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 9, pp 3662-3666, issn 0021-972X, 5 p.Article

Biologic sequelae of nuclear factor-κB blockade in multiple myeloma: therapeutic applicationsMITSIADES, Nicholas; MITSIADES, Constantine S; POULAKI, Vassiliki et al.Blood. 2002, Vol 99, Num 11, pp 4079-4086, issn 0006-4971Article

Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myelomaJAKUBIKOVA, Jana; CERVI, David; NEGRI, Joseph et al.Haematologica (Roma). 2011, Vol 96, Num 8, pp 1170-1179, issn 0390-6078, 10 p.Article

Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and BortezomibMITSIADES, Constantine S; HIDESHIMA, Teru; CHAUHAN, Dharminder et al.Seminars in hematology. 2009, Vol 46, Num 2, pp 166-175, issn 0037-1963, 10 p.Article

Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. CommentaryMITSIADES, Constantine S; POULAKI, Vassiliki; WHITE, Eileen et al.Clinical cancer research. 2006, Vol 12, Num 12, issn 1078-0432, 3648-3651, 3705-3712 [12 p.]Article